-
Something wrong with this record ?
Experimental Lung Transplantation Related With HIF-1, VEGF, ROS. Assessment of HIF-1alpha, VEGF, and Reactive Oxygen Species After Competitive Blockade of Chetomin for Lung Transplantation in Rats
C. Bravo-Reyna, A. Zentella, J. Ventura-Gallegos, G. Torres-Villalobos, V. Miranda-Galván, J. Alanis-Mendizabal, J. Escobar-Valderrama, C. Nava, N. Díaz-Martínez, T. Bliskunova, V. Morales-De Los Santos
Status minimal Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
PubMed Central
from 2020
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
PubMed
39560191
Knihovny.cz E-resources
- MeSH
- Disulfides MeSH
- Hypoxia-Inducible Factor 1, alpha Subunit * metabolism MeSH
- Indole Alkaloids MeSH
- Rats MeSH
- Lung metabolism drug effects MeSH
- Rats, Sprague-Dawley MeSH
- Reactive Oxygen Species * metabolism MeSH
- Lung Transplantation * MeSH
- Vascular Endothelial Growth Factor A * metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
UNLABELLED: Primary graft failure occurs 15 to 30 % of the time after transplantation. Although there have been improvements in preserving the lungs in good condition, there have not been studies on the regulation of transcription factors. METHODS: We carried out an experimental study involving lung transplantation to indirectly evaluate reactive oxygen species (ROS) production and VEGF expression by competitive blockade of HIF-1alpha with chetomin. There were 5 groups: Group-1: Lung blocks were perfused with 0.9 % SSF, immediately harvested, and preserved. Group-2 (I-T): Immediate transplantation and then reperfusion for 1 h. Group-3 (I-R): Lung blocks were harvested and preserved in LPD solution for 6 h and reperfused for 1 h. Group-4 (DMSO): Lung blocks were treated for 4 h with DMSO, preserved for 6 h and transplanted to a receptor treated with DMSO. Group-5 (chetomin): Lung blocks were treated for 4 h with chetomin, preserved for 6 h and transplanted to a receptor treated with chetomin. ROS, mRNA, and protein levels of HIF-1alpha and EG-VEGF were determined. RESULTS: The DMSO and chetomin groups had significantly lower ROS levels. Compared with those in the I-R group, the chetomin group exhibited the lowest level of HIF-1alpha. CONCLUSIONS: Addition of chetomin to the donor and the receptor results in a significant reduction in HIF-1A, VEGF and ROS.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24022800
- 003
- CZ-PrNML
- 005
- 20250312151307.0
- 007
- ta
- 008
- 241205s2024 xr f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)39560191
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Bravo-Reyna, C $u Experimental Surgery Department, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Vasco de Quiroga #15 Belisario Dominguez, Mexico City. carlos.bravor@incmnsz.mx
- 245 10
- $a Experimental Lung Transplantation Related With HIF-1, VEGF, ROS. Assessment of HIF-1alpha, VEGF, and Reactive Oxygen Species After Competitive Blockade of Chetomin for Lung Transplantation in Rats / $c C. Bravo-Reyna, A. Zentella, J. Ventura-Gallegos, G. Torres-Villalobos, V. Miranda-Galván, J. Alanis-Mendizabal, J. Escobar-Valderrama, C. Nava, N. Díaz-Martínez, T. Bliskunova, V. Morales-De Los Santos
- 520 9_
- $a UNLABELLED: Primary graft failure occurs 15 to 30 % of the time after transplantation. Although there have been improvements in preserving the lungs in good condition, there have not been studies on the regulation of transcription factors. METHODS: We carried out an experimental study involving lung transplantation to indirectly evaluate reactive oxygen species (ROS) production and VEGF expression by competitive blockade of HIF-1alpha with chetomin. There were 5 groups: Group-1: Lung blocks were perfused with 0.9 % SSF, immediately harvested, and preserved. Group-2 (I-T): Immediate transplantation and then reperfusion for 1 h. Group-3 (I-R): Lung blocks were harvested and preserved in LPD solution for 6 h and reperfused for 1 h. Group-4 (DMSO): Lung blocks were treated for 4 h with DMSO, preserved for 6 h and transplanted to a receptor treated with DMSO. Group-5 (chetomin): Lung blocks were treated for 4 h with chetomin, preserved for 6 h and transplanted to a receptor treated with chetomin. ROS, mRNA, and protein levels of HIF-1alpha and EG-VEGF were determined. RESULTS: The DMSO and chetomin groups had significantly lower ROS levels. Compared with those in the I-R group, the chetomin group exhibited the lowest level of HIF-1alpha. CONCLUSIONS: Addition of chetomin to the donor and the receptor results in a significant reduction in HIF-1A, VEGF and ROS.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a transplantace plic $7 D016040
- 650 12
- $a faktor 1 indukovatelný hypoxií - podjednotka alfa $x metabolismus $7 D051795
- 650 12
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 12
- $a vaskulární endoteliální růstový faktor A $x metabolismus $7 D042461
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a plíce $x metabolismus $x účinky léků $7 D008168
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a disulfidy $7 D004220
- 650 _2
- $a indolové alkaloidy $7 D026121
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zentella, A
- 700 1_
- $a Ventura-Gallegos, J
- 700 1_
- $a Torres-Villalobos, G
- 700 1_
- $a Miranda-Galván, V
- 700 1_
- $a Alanis-Mendizabal, J
- 700 1_
- $a Escobar-Valderrama, J
- 700 1_
- $a Nava, C
- 700 1_
- $a Díaz-Martínez, N
- 700 1_
- $a Bliskunova, T
- 700 1_
- $a Morales-De Los Santos, V
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 73, č. 5 (2024), s. 809-817
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39560191 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y - $z 0
- 990 __
- $a 20241205 $b ABA008
- 991 __
- $a 20250312151314 $b ABA008
- 999 __
- $a min $b bmc $g 2283529 $s 1234805
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 73 $c 5 $d 809-817 $e 20241119 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
- LZP __
- $a Pubmed-20241205